1
|
Perez-Restrepo LS, Ciuoderis K, Usuga J, Moreno I, Vargas V, Arévalo-Arbelaez AJ, Berg MG, Cloherty GA, Hernández-Ortiz JP, Osorio JE. Mayaro Virus as the cause of Acute Febrile Illness in the Colombian Amazon Basin. Front Microbiol 2024; 15:1419637. [PMID: 39044955 PMCID: PMC11263195 DOI: 10.3389/fmicb.2024.1419637] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2024] [Accepted: 06/25/2024] [Indexed: 07/25/2024] Open
Abstract
Introduction Mayaro Fever (MF) is a tropical disease caused by the Mayaro virus (MAYV), with outbreaks documented in Latin America. Methods A hospital-based fever surveillance in Leticia, Colombian Amazon, collected sera from 1,460 patients aged 5-89 between December 2020 and April 2023. Results Dengue and malaria were the main diagnoses (19.4 and 5.8%, respectively), leaving 71.4% of cases unidentified after testing. Metagenomic sequencing and real-time RT-qPCR testing identified MAYV in two patients (25-year-old male and an 80-year-old female) exhibiting typical symptoms, of MF including rash, joint pain, and fever. Phylogenetics analysis of these two viruses revealed a close relationship to Peruvian strains within the MAYV D genotype. Discussion The study of AFI in Leticia, Colombia, identified dengue as prevalent, with malaria, COVID-19, Influenza, and Zika viruses also detected. Despite extensive testing, most cases remained unexplained until metagenomic sequencing revealed MAYV, previously unseen in Colombia but known in neighboring countries. Conclusion This study presents the first near full-length genomes of MAYV in Colombia, highlighting the need for further seroprevalence studies and enhanced surveillance to understand and control the spread of the virus in the region.
Collapse
Affiliation(s)
- Laura S. Perez-Restrepo
- GHI One Health Colombia, Universidad Nacional de Colombia, Medellín, Colombia
- Abbott Pandemic Defense Coalition, Chicago, IL, United States
| | - Karl Ciuoderis
- GHI One Health Colombia, Universidad Nacional de Colombia, Medellín, Colombia
- Abbott Pandemic Defense Coalition, Chicago, IL, United States
| | - Jaime Usuga
- GHI One Health Colombia, Universidad Nacional de Colombia, Medellín, Colombia
- Abbott Pandemic Defense Coalition, Chicago, IL, United States
| | - Isabel Moreno
- GHI One Health Colombia, Universidad Nacional de Colombia, Medellín, Colombia
- Abbott Pandemic Defense Coalition, Chicago, IL, United States
| | - Vanessa Vargas
- GHI One Health Colombia, Universidad Nacional de Colombia, Medellín, Colombia
- Abbott Pandemic Defense Coalition, Chicago, IL, United States
| | - Angela J. Arévalo-Arbelaez
- GHI One Health Colombia, Universidad Nacional de Colombia, Medellín, Colombia
- Abbott Pandemic Defense Coalition, Chicago, IL, United States
| | - Michael G. Berg
- Abbott Pandemic Defense Coalition, Chicago, IL, United States
- Infectious Diseases Research, Abbott Diagnostics, Abbott Park, IL, United States
| | - Gavin A. Cloherty
- Abbott Pandemic Defense Coalition, Chicago, IL, United States
- Infectious Diseases Research, Abbott Diagnostics, Abbott Park, IL, United States
| | - Juan Pablo Hernández-Ortiz
- GHI One Health Colombia, Universidad Nacional de Colombia, Medellín, Colombia
- Abbott Pandemic Defense Coalition, Chicago, IL, United States
- Faculty of Life Sciences, Universidad Nacional de Colombia, Medellín, Colombia
| | - Jorge E. Osorio
- GHI One Health Colombia, Universidad Nacional de Colombia, Medellín, Colombia
- Abbott Pandemic Defense Coalition, Chicago, IL, United States
- Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI, United States
- Global Health Institute, University of Wisconsin, Madison, WI, United States
| |
Collapse
|
2
|
Koudokpon H, Lègba B, Sintondji K, Kissira I, Kounou A, Guindo I, Koné KM, Abdou M, Koné A, Sambou C, Bankolé H, Yadouleton A, Dougnon V. Empowering public health: building advanced molecular surveillance in resource-limited settings through collaboration and capacity-building. FRONTIERS IN HEALTH SERVICES 2024; 4:1289394. [PMID: 38957804 PMCID: PMC11217560 DOI: 10.3389/frhs.2024.1289394] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/06/2023] [Accepted: 05/31/2024] [Indexed: 07/04/2024]
Abstract
The rapid detection and continuous surveillance of infectious diseases are important components of an effective public health response. However, establishing advanced molecular surveillance systems, crucial for monitoring and mitigating pandemics, poses significant challenges in resource-limited developing countries. In a collaborative effort, research institutions from Benin joined forces with Mali's National Institute of Public Health to implement a state-of-the-art molecular surveillance system in Mali. This approach was characterized by collaboration, multidisciplinarity, and tutoring. Key activities included a comprehensive assessment of infrastructure and human resources through document reviews, interviews, and laboratory visits; the development and validation of Standard Operating Procedures (SOPs) for advanced molecular surveillance following an inclusive approach; capacity-building initiatives for 25 biologists in Mali on sequencing techniques; and international tutoring sessions for eight Malian professionals held in Benin. These collective efforts enabled Mali to establish an advanced molecular surveillance system aligned with the WHO's global strategy for genomic surveillance. This manuscript aims to share experiences, insights, and outcomes from this initiative, with the hope of contributing to the broader discussion on strengthening global health security through collaborative approaches and capacity-building efforts, particularly in developing countries.
Collapse
Affiliation(s)
- Hornel Koudokpon
- Research Unit in Applied Microbiology and Pharmacology of Natural Substances, Research Laboratory in Applied Biology, Polytechnic School of Abomey-Calavi, University of Abomey-Calavi, Cotonou, Benin
| | - Boris Lègba
- Research Unit in Applied Microbiology and Pharmacology of Natural Substances, Research Laboratory in Applied Biology, Polytechnic School of Abomey-Calavi, University of Abomey-Calavi, Cotonou, Benin
| | - Kevin Sintondji
- Research Unit in Applied Microbiology and Pharmacology of Natural Substances, Research Laboratory in Applied Biology, Polytechnic School of Abomey-Calavi, University of Abomey-Calavi, Cotonou, Benin
| | - Islamiath Kissira
- Research Unit in Applied Microbiology and Pharmacology of Natural Substances, Research Laboratory in Applied Biology, Polytechnic School of Abomey-Calavi, University of Abomey-Calavi, Cotonou, Benin
| | - Arielle Kounou
- Research Unit in Applied Microbiology and Pharmacology of Natural Substances, Research Laboratory in Applied Biology, Polytechnic School of Abomey-Calavi, University of Abomey-Calavi, Cotonou, Benin
| | - Ibrehima Guindo
- National Institute of Public Health, Laboratory and Biomedical Research Department, Bamako, Mali
| | - Kléma Marcel Koné
- National Institute of Public Health, Laboratory and Biomedical Research Department, Bamako, Mali
| | - Mahamadou Abdou
- National Institute of Public Health, Laboratory and Biomedical Research Department, Bamako, Mali
| | - Amadou Koné
- University Clinical Research Center, University of Sciences, Techniques and Technology, Bamako, Mali
| | - Claire Sambou
- Project Responses to the various Crises Caused by COVID-19 in Mali (RC3-Mali), Health Department, Expertise France, Bamako, Mali
| | - Honoré Bankolé
- Research Unit in Applied Microbiology and Pharmacology of Natural Substances, Research Laboratory in Applied Biology, Polytechnic School of Abomey-Calavi, University of Abomey-Calavi, Cotonou, Benin
| | - Anges Yadouleton
- Hemorrhagic and Viral Fevers Laboratory, Ministry of Health, Cotonou, Benin
| | - Victorien Dougnon
- Research Unit in Applied Microbiology and Pharmacology of Natural Substances, Research Laboratory in Applied Biology, Polytechnic School of Abomey-Calavi, University of Abomey-Calavi, Cotonou, Benin
| |
Collapse
|
3
|
Orf GS, Ahouidi AD, Mata M, Diedhiou C, Mboup A, Padane A, Manga NM, Dela-del Lawson AT, Averhoff F, Berg MG, Cloherty GA, Mboup S. Next-generation sequencing survey of acute febrile illness in Senegal (2020-2022). Front Microbiol 2024; 15:1362714. [PMID: 38655084 PMCID: PMC11037400 DOI: 10.3389/fmicb.2024.1362714] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2023] [Accepted: 03/13/2024] [Indexed: 04/26/2024] Open
Abstract
Introduction Acute febrile illnesses (AFI) in developing tropical and sub-tropical nations are challenging to diagnose due to the numerous causes and non-specific symptoms. The proliferation of rapid diagnostic testing and successful control campaigns against malaria have revealed that non-Plasmodium pathogens still contribute significantly to AFI burden. Thus, a more complete understanding of local trends and potential causes is important for selecting the correct treatment course, which in turn will reduce morbidity and mortality. Next-generation sequencing (NGS) in a laboratory setting can be used to identify known and novel pathogens in individuals with AFI. Methods In this study, plasma was collected from 228 febrile patients tested negative for malaria at clinics across Senegal from 2020-2022. Total nucleic acids were extracted and converted to metagenomic NGS libraries. To identify viral pathogens, especially those present at low concentration, an aliquot of each library was processed with a viral enrichment panel and sequenced. Corresponding metagenomic libraries were also sequenced to identify non-viral pathogens. Results and Discussion Sequencing reads for pathogens with a possible link to febrile illness were identified in 51/228 specimens, including (but not limited to): Borrelia crocidurae (N = 7), West Nile virus (N = 3), Rickettsia felis (N = 2), Bartonella quintana (N = 1), human herpesvirus 8 (N = 1), and Saffold virus (N = 1). Reads corresponding to Plasmodium falciparum were detected in 19 specimens, though their presence in the cohort was likely due to user error of rapid diagnostic testing or incorrect specimen segregation at the clinics. Mosquito-borne pathogens were typically detected just after the conclusion of the rainy season, while tick-borne pathogens were mostly detected before the rainy season. The three West Nile virus strains were phylogenetically characterized and shown to be related to both European and North American clades. Surveys such as this will increase the understanding of the potential causes of non-malarial AFI, which may help inform diagnostic and treatment options for clinicians who provide care to patients in Senegal.
Collapse
Affiliation(s)
- Gregory S. Orf
- Core Diagnostics, Abbott Laboratories, Abbott Park, IL, United States
- Abbott Pandemic Defense Coalition, Abbott Park, IL, United States
| | - Ambroise D. Ahouidi
- Abbott Pandemic Defense Coalition, Abbott Park, IL, United States
- Institut de Recherche en Santé, de Surveillance Epidémiologique et de Formation, Dakar, Senegal
| | - Maximillian Mata
- Core Diagnostics, Abbott Laboratories, Abbott Park, IL, United States
- Abbott Pandemic Defense Coalition, Abbott Park, IL, United States
| | - Cyrille Diedhiou
- Abbott Pandemic Defense Coalition, Abbott Park, IL, United States
- Institut de Recherche en Santé, de Surveillance Epidémiologique et de Formation, Dakar, Senegal
| | - Aminata Mboup
- Abbott Pandemic Defense Coalition, Abbott Park, IL, United States
- Institut de Recherche en Santé, de Surveillance Epidémiologique et de Formation, Dakar, Senegal
| | - Abdou Padane
- Abbott Pandemic Defense Coalition, Abbott Park, IL, United States
- Institut de Recherche en Santé, de Surveillance Epidémiologique et de Formation, Dakar, Senegal
| | - Noel Magloire Manga
- Unit of Infectious and Tropical Diseases, Université Assane Seck, Hôpital de la Paix, Ziguinchor, Senegal
| | | | - Francisco Averhoff
- Core Diagnostics, Abbott Laboratories, Abbott Park, IL, United States
- Abbott Pandemic Defense Coalition, Abbott Park, IL, United States
| | - Michael G. Berg
- Core Diagnostics, Abbott Laboratories, Abbott Park, IL, United States
- Abbott Pandemic Defense Coalition, Abbott Park, IL, United States
| | - Gavin A. Cloherty
- Core Diagnostics, Abbott Laboratories, Abbott Park, IL, United States
- Abbott Pandemic Defense Coalition, Abbott Park, IL, United States
| | - Souleymane Mboup
- Abbott Pandemic Defense Coalition, Abbott Park, IL, United States
- Institut de Recherche en Santé, de Surveillance Epidémiologique et de Formation, Dakar, Senegal
| |
Collapse
|
4
|
Ciuoderis KA, Usuga J, Moreno I, Perez-Restrepo LS, Flórez DY, Cardona A, Cloherty GA, Berg MG, Hernandez-Ortiz JP, Osorio JE. Characterization of Dengue Virus Serotype 2 Cosmopolitan Genotype Circulating in Colombia. Am J Trop Med Hyg 2023; 109:1298-1302. [PMID: 37972339 DOI: 10.4269/ajtmh.23-0375] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2023] [Accepted: 08/22/2023] [Indexed: 11/19/2023] Open
Abstract
Dengue virus (DENV) is the etiological agent of dengue fever (DF), which is among the most prevalent vector-borne diseases in the tropics. In 2022, the Colombian health surveillance system reported more than 69,000 cases of DF. As part of a hospital-based fever surveillance study, acute-phase sera were collected from 4,545 patients with suspected dengue between 2020 and 2023 in three municipalities of Colombia. Combined reverse transcription-polymerase chain reaction and antigen rapid testing confirmed that 376 patients (8.3%) had DF. The virus was isolated in cell culture from 166 of these patients (44.1%), and genome sequencing was performed successfully on 122 (73.5%). Three DENV serotypes (1, 2, and 3) were identified. Phylogenetic analyses of the DENV-2 sequences revealed that 42 of 50 of the isolates (84%) belonged to the DENV-2 cosmopolitan genotype lineage, clustering with sequences from Asia, Peru, and Brazil. We report the detection, isolation, and whole-genome sequencing (11 Kb) of the DENV-2 cosmopolitan genotype and its recent introduction to Colombia.
Collapse
Affiliation(s)
- Karl A Ciuoderis
- GHI One Health Colombia, Universidad Nacional de Colombia, Medellín, Colombia
| | - Jaime Usuga
- GHI One Health Colombia, Universidad Nacional de Colombia, Medellín, Colombia
| | - Isabel Moreno
- GHI One Health Colombia, Universidad Nacional de Colombia, Medellín, Colombia
| | | | - Diana Y Flórez
- GHI One Health Colombia, Universidad Nacional de Colombia, Medellín, Colombia
| | - Andres Cardona
- GHI One Health Colombia, Universidad Nacional de Colombia, Medellín, Colombia
| | - Gavin A Cloherty
- Infectious Diseases Research, Abbott Diagnostics, Abbott Park, Illinois
| | - Michael G Berg
- Infectious Diseases Research, Abbott Diagnostics, Abbott Park, Illinois
| | - Juan P Hernandez-Ortiz
- GHI One Health Colombia, Universidad Nacional de Colombia, Medellín, Colombia
- Department of Materials and Nanotechnology, Universidad Nacional de Colombia, Medellín, Colombia
| | - Jorge E Osorio
- Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, Wisconsin
- Global Health Institute, University of Wisconsin, Madison, Wisconsin
| |
Collapse
|
5
|
Ciuoderis KA, Berg MG, Perez LJ, Hadji A, Perez-Restrepo LS, Aristizabal LC, Forberg K, Yamaguchi J, Cardona A, Weiss S, Qiu X, Hernandez-Ortiz JP, Averhoff F, Cloherty GA, Osorio JE. Oropouche virus as an emerging cause of acute febrile illness in Colombia. Emerg Microbes Infect 2022; 11:2645-2657. [PMID: 36239235 PMCID: PMC9639516 DOI: 10.1080/22221751.2022.2136536] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Arbovirus infections are frequent causes of acute febrile illness (AFI) in tropical countries. We conducted health facility-based AFI surveillance at four sites in Colombia (Cucuta, Cali, Villavicencio, Leticia) during 2019-2022. Demographic, clinical and risk factor data were collected from persons with AFI that consented to participate in the study (n = 2,967). Serologic specimens were obtained and tested for multiple pathogens by RT-PCR and rapid test (Antigen/IgM), with 20.7% identified as dengue positive from combined testing. Oropouche virus (OROV) was initially detected in serum by metagenomic next-generation sequencing (mNGS) and virus target capture in a patient from Cúcuta. Three additional infections from Leticia were confirmed by conventional PCR, sequenced, and isolated in tissue culture. Phylogenetic analysis determined there have been at least two independent OROV introductions into Colombia. To assess OROV spread, a RT-qPCR dual-target assay was developed which identified 87/791 (10.9%) viremic cases in AFI specimens from Cali (3/53), Cucuta (3/19), Villavicencio (38/566), and Leticia (43/153). In parallel, an automated anti-nucleocapsid antibody assay detected IgM in 27/503 (5.4%) and IgG in 92/568 (16.2%) patients screened, for which 24/68 (35.3%) of PCR positives had antibodies. Dengue was found primarily in people aged <18 years and linked to several clinical manifestations (weakness, skin rash and petechiae), whereas Oropouche cases were associated with the location, climate phase, and odynophagia symptom. Our results confirm OROV as an emerging pathogen and recommend increased surveillance to determine its burden as a cause of AFI in Colombia.
Collapse
Affiliation(s)
- Karl A. Ciuoderis
- Global Health Institute One-Health Colombia, Universidad Nacional de Colombia, Medellín, Colombia,Abbott Pandemic Defense Coalition, Chicago, IL, USA, Karl A Ciuoderis Colombia/Wisconsin One Health Consortium (CWOHC), Universidad Nacional de Colombia, Medellín, ColombiaAbbott Pandemic Defense Coalition
| | - Michael G. Berg
- Infectious Diseases Research, Abbott Diagnostics, Abbott Park, IL, USA,Abbott Pandemic Defense Coalition, Chicago, IL, USA
| | - Lester J. Perez
- Infectious Diseases Research, Abbott Diagnostics, Abbott Park, IL, USA,Abbott Pandemic Defense Coalition, Chicago, IL, USA
| | - Abbas Hadji
- Infectious Diseases Research, Abbott Diagnostics, Abbott Park, IL, USA,Abbott Pandemic Defense Coalition, Chicago, IL, USA
| | - Laura S. Perez-Restrepo
- Global Health Institute One-Health Colombia, Universidad Nacional de Colombia, Medellín, Colombia,Abbott Pandemic Defense Coalition, Chicago, IL, USA
| | - Leidi Carvajal Aristizabal
- Global Health Institute One-Health Colombia, Universidad Nacional de Colombia, Medellín, Colombia,Abbott Pandemic Defense Coalition, Chicago, IL, USA
| | - Kenn Forberg
- Infectious Diseases Research, Abbott Diagnostics, Abbott Park, IL, USA,Abbott Pandemic Defense Coalition, Chicago, IL, USA
| | - Julie Yamaguchi
- Infectious Diseases Research, Abbott Diagnostics, Abbott Park, IL, USA,Abbott Pandemic Defense Coalition, Chicago, IL, USA
| | - Andres Cardona
- Global Health Institute One-Health Colombia, Universidad Nacional de Colombia, Medellín, Colombia,Abbott Pandemic Defense Coalition, Chicago, IL, USA
| | - Sonja Weiss
- Infectious Diseases Research, Abbott Diagnostics, Abbott Park, IL, USA,Abbott Pandemic Defense Coalition, Chicago, IL, USA
| | - Xiaoxing Qiu
- Infectious Diseases Research, Abbott Diagnostics, Abbott Park, IL, USA,Abbott Pandemic Defense Coalition, Chicago, IL, USA
| | - Juan Pablo Hernandez-Ortiz
- Global Health Institute One-Health Colombia, Universidad Nacional de Colombia, Medellín, Colombia,Abbott Pandemic Defense Coalition, Chicago, IL, USA
| | - Francisco Averhoff
- Infectious Diseases Research, Abbott Diagnostics, Abbott Park, IL, USA,Abbott Pandemic Defense Coalition, Chicago, IL, USA
| | - Gavin A. Cloherty
- Infectious Diseases Research, Abbott Diagnostics, Abbott Park, IL, USA,Abbott Pandemic Defense Coalition, Chicago, IL, USA
| | - Jorge E. Osorio
- Global Health Institute One-Health Colombia, Universidad Nacional de Colombia, Medellín, Colombia,Global Health Institute, University of Wisconsin, Madison, WI, USA,Abbott Pandemic Defense Coalition, Chicago, IL, USA
| |
Collapse
|
6
|
Orf GS, Forberg K, Meyer TV, Mowerman I, Mohaimani A, Faron ML, Jennings C, Landay AL, Goldstein DY, Fox AS, Berg MG, Cloherty GA. SNP and Phylogenetic Characterization of Low Viral Load SARS-CoV-2 Specimens by Target Enrichment. FRONTIERS IN VIROLOGY 2021. [DOI: 10.3389/fviro.2021.765974] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Abstract
Background: Surveillance of SARS-CoV-2 across the globe has enabled detection of new variants and informed the public health response. With highly sensitive methods like qPCR widely adopted for diagnosis, the ability to sequence and characterize specimens with low titers needs to keep pace.Methods: Nucleic acids extracted from nasopharyngeal swabs collected from four sites in the United States in early 2020 were converted to NGS libraries to sequence SARS-CoV-2 genomes using metagenomic and xGen target enrichment approaches. Single nucleotide polymorphism (SNP) analysis and phylogeny were used to determine clade assignments and geographic origins of strains.Results: SARS-CoV-2-specific xGen enrichment enabled full genome coverage for 87 specimens with Ct values <29, corresponding to viral loads of >10,000 cp/ml. For samples with viral loads between 103 and 106 cp/ml, the median genome coverage for xGen was 99.1%, sequence depth was 605X, and the “on-target” rate was 57 ± 21%, compared to 13%, 2X and 0.001 ± 0.016%, respectively, for metagenomic sequencing alone. Phylogenetic analysis revealed the presence of most clades that existed at the time of the study, though clade GH dominated in the Midwest.Conclusions: Even as vaccines are being widely distributed, a high case load of SARS-CoV-2 infection persists around the world. Viral genetic surveillance has succeeded in warning the public of new variants in circulation and ensured that diagnostic tools remain resilient to a steadily increasing number of mutations. Target capture offers a means of characterizing low viral load samples which would normally pose a challenge for metagenomic sequencing.
Collapse
|